Ticker Scorecard - INZY Basics Company: Inozyme Pharma, Inc. IPO Date: July 24, 2020 Sector: Healthcare Industry: Biotech Market Cap: $188.22M Activated in VL: True Average Daily Range Avg Daily Range: $0.31 | 3.68% Avg Daily Range (30 D): $0.11 | 4.08% Avg Daily Range (90 D): $0.13 | 3.38% Institutional Daily Volume Avg Daily Volume: .3M Avg Daily Volume (30 D): .69M Avg Daily Volume (90 D): .38M Trade Size Avg Trade Size (Sh.): 125 Avg Trade Size (Sh.) (30 D): 149 Avg Trade Size (Sh.) (90 D): 122 Institutional Trades Total Inst.Trades: 118 Avg Inst. Trade: $1.64M Avg Inst. Trade (30 D): $3.78M Avg Inst. Trade (90 D): $2.18M Avg Inst. Trade Volume: .22M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.18M Avg Closing Trade (30 D): $1.38M Avg Closing Trade (90 D): $1.38M Avg Closing Volume: 410.99K     News Jul 2, 2024 @ 12:30 PM Inozyme Pharma Announces FDA Fast Track Designatio... Source: Inozyme Pharma Inc. Jun 21, 2024 @ 5:00 PM Inozyme Pharma Announces Presentation and Sponsore... Source: Inozyme Pharma Inc. May 23, 2024 @ 12:30 PM Inozyme Pharma to Present Recently Announced Data ... Source: Inozyme Pharma Inc. May 8, 2024 @ 12:30 PM Inozyme Pharma to Participate at the Bank of Ameri... Source: Inozyme Pharma Inc. May 7, 2024 @ 12:30 PM Inozyme Pharma Reports First Quarter 2024 Financia... Source: Inozyme Pharma Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.55 $-.39 $-.44 Diluted EPS $-1.55 $-.39 $-.44 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -96.49M $ -24.57M $ -27.03M Operating Income / Loss $ -99.67M $ -24.85M $ -27.67M Cost of Revenue $ $ $ Net Cash Flow $ -22.46M $ 9.34M $ -5.38M PE Ratio